Skip to content
healthcare.dev

Mucus Relief

NDC 83324-097, Guaifenesin, tablet, extended release, from CHAIN DRUG MARKETING ASSOCIATION, INC..

Product NDC
83324-097
Status
Listed
Labeler
CHAIN DRUG MARKETING ASSOCIATION, INC.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83324-097 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
83324-097-20833240097201 BLISTER PACK in 1 CARTON (83324-097-20) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 83324009720

    GET /v1/drugs/nadac/83324009720

Use it

Look up 83324-097 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83324-097 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83324-097. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.